In biotech, if you want to bring your drug candidate to the market, it has to go through human trials. Human trials are prohibitively expensive (anywhere between USD 10-120 million), so only a pharmaceutical giant can readily afford them.
Selling your biotech startup to one of these is the difference between your product ever seeing the market – or not.
Latest Answers